×
About 873 results

ALLMedicine™ Hepatitis D Center

Research & Reviews  294 results

BULEVIRTIDE WITH OR WITHOUT PEGIFNα FOR PATIENTS WITH COMPENSATED CHRONIC HEPATITIS DEL...
https://doi.org/10.1016/j.jhep.2022.06.010
Journal of Hepatology; Lampertico P, Roulot D et. al.

Jun 26th, 2022 - Chronic hepatitis D (CHD) is the most severe form of viral hepatitis, displaying a superior risk of cirrhosis, hepatic decompensation and hepatocellular carcinoma (HCC). Pegylated-Interferon α (pegIFNα), the only off-label therapeutic option that ...

Viral Hepatitis in Pregnancy.
https://doi.org/10.1111/jvh.13725
Journal of Viral Hepatitis; Shata MTM, Hetta HF et. al.

Jun 25th, 2022 - Viral hepatitis is caused by a heterogenous group of viral agents representing a wide range of phylogenetic groups. Many viruses can involve the liver and cause liver injury but only a subset are delineated as "hepatitis viruses" based upon their ...

HERACLIS-TAF: a multicentre prospective cohort study on 2-year safety and efficacy of t...
https://doi.org/10.1111/apt.17093
Alimentary Pharmacology & Therapeutics; Papatheodoridis GV, Mimidis K et. al.

Jun 24th, 2022 - Tenofovir alafenamide (TAF) has exhibited a favourable safety profile on estimated glomerular filtration (eGFR) and bone mineral density (BMD) , but has not been extensively studied in patients with renal impairment and/or BMD disorders. To assess...

Prevalence of Hepatitis in Prisoners: A Systematic Review of Current Evidence.
https://doi.org/10.2174/1871526522666220620115006
Infectious Disorders Drug Targets; Pashangzadeh S, Seyed Alinaghi SA et. al.

Jun 22nd, 2022 - Prisoners represent high-risk behaviors such as injecting drug use, sharing syringes, tattooing, and unprotected sexual intercourse. The authors aimed to study the prevalence of hepatitis B, hepatitis C, and hepatitis D in the prisoners. We conduc...

The Relationship Between Long-term Oral Anti Hepatitis B Nucleoside Analogs and Hepatic Steatosis
https://clinicaltrials.gov/ct2/show/NCT05416008

Jun 13th, 2022 - This is a single-center, prospective, observational study involving chronic hepatitis B patients from the Second Affiliated Hospital of Chongqing Medical University. Research implementation process and route Recruitment object: Patients with chron...

see more →

Clinicaltrials.gov  28 results

The Relationship Between Long-term Oral Anti Hepatitis B Nucleoside Analogs and Hepatic Steatosis
https://clinicaltrials.gov/ct2/show/NCT05416008

Jun 13th, 2022 - This is a single-center, prospective, observational study involving chronic hepatitis B patients from the Second Affiliated Hospital of Chongqing Medical University. Research implementation process and route Recruitment object: Patients with chron...

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
https://clinicaltrials.gov/ct2/show/NCT04535544

Jun 8th, 2022 - JNJ-73763989 is a liver-targeted antiviral therapeutic for subcutaneous injection designed to treat chronic hepatitis B virus (HBV) infection via ribonucleic acid interference mechanism. This phase 2 study is designed to evaluate safety and effica...

Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)
https://clinicaltrials.gov/ct2/show/NCT05394623

May 27th, 2022 - In China, there is no recommendation for Hepatitis D virus (HDV) screening, but the fact is estimated that one-third of the world's population of individuals with chronic Hepatitis B virus (HBV) infection live in China while we do not know the pre...

A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection
https://clinicaltrials.gov/ct2/show/NCT04847440

May 19th, 2022 - This is a randomized, double-blinded, placebo-controlled, multi center, dose ranging study of safety and efficacy in both volunteers with chronic hepatitis B virus infection and in volunteers with hepatitis D virus coinfection. Volunteers will be ...

Difference in Patterns of Liver Diseases Related Admissions After the Era of DAAS
https://clinicaltrials.gov/ct2/show/NCT05284916

Mar 17th, 2022 - Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular carcinoma Hepatitis is defined as inflammation of the liver that can ...

see more →

News  24 results

Hepatis D virus linked to liver cancer in patients with chronic HBV
https://www.mdedge.com/fedprac/article/240484/hepatocellular-carcinoma/hepatis-d-virus-linked-liver-cancer-patients-chronic

May 24th, 2021 - Key clinical point: Consider testing for hepatitis D virus in patients receiving nucleoside/nucleotide analogues (NA) for chronic hepatitis B virus infection (HBV). Major finding: Prevalences of anti-HDV and HDV RNA positivity were 2.

Consider hepatitis D testing for patients receiving nucleoside analogues
https://www.mdedge.com/fedprac/article/240241/hepatocellular-carcinoma/clinical-edge-journal-scan-commentary-hcc-may-2021
Nevena Damjanov, MD

May 17th, 2021 - Nevena Damjanov, MD This month’s articles investigate earlier diagnosis of new or recurrent hepatocellular carcinoma (HCC). The first study looked at patients with hepatitis B virus (HBV) infection, trying to identify those at higher risk for deve.

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 13th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Hepatitis D Virus Coinfection Boosts HBV Healthcare Costs
https://www.medscape.com/viewarticle/922853

Dec 20th, 2019 - NEW YORK (Reuters Health) - Hepatitis delta virus (HDV) infection, which occurs only as a co-infection with acute hepatitis B (HBV) or a superinfection with chronic HBV, is associated with higher healthcare utilization and costs than HBV alone, a ...

HDV combo therapy reduces viral loads
https://www.mdedge.com/gihepnews/article/211868/hepatology/hdv-combo-therapy-reduces-viral-loads?channel=346
Will Pass, MDedge News

Nov 8th, 2019 - BOSTON – For most patients with chronic hepatitis D virus (HDV) infection, combination therapy with lonafarnib, ritonavir, and peginterferon may significantly decrease viral loads, based on interim results from the phase IIa LIFT trial. After 6 mo.

see more →

Patient Education  3 results see all →